BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 954 filers reported holding BAXTER INTL INC in Q1 2014. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $454,000 | -61.0% | 3,875 | -73.2% | 0.18% | -37.0% |
| Q2 2021 | $1,165,000 | -6.0% | 14,476 | -1.4% | 0.29% | -11.1% |
| Q1 2021 | $1,239,000 | +4.5% | 14,685 | -0.7% | 0.32% | -23.0% |
| Q4 2020 | $1,186,000 | -1.3% | 14,783 | -1.1% | 0.42% | -8.3% |
| Q3 2020 | $1,202,000 | -7.8% | 14,951 | -1.3% | 0.46% | -17.7% |
| Q2 2020 | $1,304,000 | +6.9% | 15,147 | +0.8% | 0.56% | -13.3% |
| Q1 2020 | $1,220,000 | -5.3% | 15,032 | -2.4% | 0.64% | +28.7% |
| Q4 2019 | $1,288,000 | -13.3% | 15,402 | -9.3% | 0.50% | -25.1% |
| Q3 2019 | $1,485,000 | +4.7% | 16,977 | -1.9% | 0.67% | +3.7% |
| Q2 2019 | $1,418,000 | +0.7% | 17,312 | 0.0% | 0.64% | +3.0% |
| Q1 2019 | $1,408,000 | +23.1% | 17,312 | -0.4% | 0.63% | +8.5% |
| Q4 2018 | $1,144,000 | -17.9% | 17,380 | -3.9% | 0.58% | -2.4% |
| Q3 2018 | $1,394,000 | +1.9% | 18,080 | -2.4% | 0.59% | -4.2% |
| Q2 2018 | $1,368,000 | +13.0% | 18,525 | -0.5% | 0.62% | +14.0% |
| Q1 2018 | $1,211,000 | +0.6% | 18,625 | 0.0% | 0.54% | +18.1% |
| Q4 2017 | $1,204,000 | +2.6% | 18,625 | -0.4% | 0.46% | -8.2% |
| Q3 2017 | $1,173,000 | +4.3% | 18,691 | +0.6% | 0.50% | +0.8% |
| Q2 2017 | $1,125,000 | +19.9% | 18,579 | +2.8% | 0.50% | -6.2% |
| Q1 2017 | $938,000 | +17.4% | 18,079 | +0.3% | 0.53% | +8.2% |
| Q4 2016 | $799,000 | -6.9% | 18,025 | 0.0% | 0.49% | -18.4% |
| Q3 2016 | $858,000 | -25.0% | 18,025 | -28.8% | 0.60% | -6.3% |
| Q2 2016 | $1,144,000 | +2.9% | 25,300 | -6.6% | 0.64% | -10.5% |
| Q1 2016 | $1,112,000 | +7.5% | 27,075 | -0.1% | 0.71% | +6.7% |
| Q4 2015 | $1,034,000 | +13.4% | 27,110 | -2.3% | 0.67% | +9.0% |
| Q3 2015 | $912,000 | -53.0% | 27,760 | 0.0% | 0.61% | -47.7% |
| Q2 2015 | $1,941,000 | +2.1% | 27,760 | 0.0% | 1.17% | +4.3% |
| Q1 2015 | $1,902,000 | -6.5% | 27,760 | 0.0% | 1.12% | -7.9% |
| Q4 2014 | $2,035,000 | -5.9% | 27,760 | -7.9% | 1.22% | -14.4% |
| Q3 2014 | $2,162,000 | -1.0% | 30,125 | -0.2% | 1.42% | -2.7% |
| Q2 2014 | $2,183,000 | -2.1% | 30,200 | -0.3% | 1.46% | -6.5% |
| Q1 2014 | $2,230,000 | +7.8% | 30,305 | +1.8% | 1.56% | +7.5% |
| Q4 2013 | $2,069,000 | +9.9% | 29,755 | +3.8% | 1.46% | -0.5% |
| Q3 2013 | $1,883,000 | -5.3% | 28,670 | -0.1% | 1.46% | -9.6% |
| Q2 2013 | $1,988,000 | – | 28,703 | – | 1.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
| GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
| Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
| Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
| Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
| Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
| TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
| CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
| Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
| Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |